OTC · Financial Statements
MGC Pharmaceuticals Limited (MGCLF) Financial Statements
$0.27
OTC: MGCLF
Market Cap $12.11M
Overview Financials Dividend MGC Pharmaceuticals Limited most recently reported annual revenue of $3.0M, net profit of $-21.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2019 2020 2021 2022 2023 Revenue $1.0M $2.0M $3.0M $5.0M $3.0M Operating Profit $-9.0M $-12.0M $-12.0M $-15.0M $-15.0M Net Profit $-11.0M $-19.0M $-16.0M $-20.0M $-21.0M EPS $-9.11 $-14.00 $-8.30 $-7.90 $-7.07 Op Margin -1327.6% -567.8% -398.5% -327.5% -457.3%
Balance Sheet (USD)
Metric 2019 2020 2021 2022 2023 Total Assets $13.0M $8.0M $24.0M $19.0M $10.0M Total Liabilities $2.0M $5.0M $10.0M $13.0M $18.0M Cash $2.0M $2.0M $5.0M $2.0M $0 Borrowings $0 $2.0M $6.0M $4.0M $10.0M
Cash Flow (USD)
Metric 2019 2020 2021 2022 2023 Operating Cash Flow $-6.0M $-10.0M $-12.0M $-12.0M $-12.0M Investing Cash Flow $-2.0M $-2.0M $-5.0M $-4.0M $0 Financing Cash Flow $0 $10.0M $16.0M $9.0M $9.0M Net Cash Flow $-8.0M $0 $4.0M $-4.0M $-2.0M Free Cash Flow $-7.0M $-11.0M $-15.0M $-15.0M $-12.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA -1.37 FCF Yield -66.11% Quick Ratio 0.09 Interest Coverage -60.19 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock